Skip to main content

MoonLake Immunotherapeutics - Class A Ordinary Shares (NQ: MLTX )

45.02 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
December 09, 2018
Form NT 10-Q
Source: SEC/Edgar
August 14, 2018
Form 8-K
Source: SEC/Edgar
July 31, 2018
Form 8-K
Source: SEC/Edgar
May 08, 2018
Form 8-K/A
Source: SEC/Edgar
April 05, 2018
Form NT 10-K
Source: SEC/Edgar
April 02, 2018
Form 8-K
Source: SEC/Edgar
January 08, 2018
Form 8-K
Source: SEC/Edgar
December 19, 2017
Form 8-K
Source: SEC/Edgar
November 30, 2017
Form 8-K
Source: SEC/Edgar
November 19, 2017
Form CT ORDER
Source: SEC/Edgar
August 31, 2017
Form 8-K
Source: SEC/Edgar
February 15, 2017
Form SC 13D
Source: SEC/Edgar
February 13, 2017
Form 8-K
Source: SEC/Edgar
October 27, 2016
Form DEFR14A
Source: SEC/Edgar
October 04, 2016
Form DEF 14A
Source: SEC/Edgar
October 03, 2016
Form 10-K/A
Source: SEC/Edgar
September 01, 2016
Form 10-K/A
Source: SEC/Edgar
September 01, 2016
Form 10-K/A
Source: SEC/Edgar
August 31, 2016
Form 8-K
Source: SEC/Edgar
July 25, 2016
Form 8-K/A
Source: SEC/Edgar
July 24, 2016
Form 8-K
Source: SEC/Edgar
July 20, 2016
Form 8-K
Source: SEC/Edgar
May 10, 2016
Form 8-K/A
Source: SEC/Edgar
May 09, 2016
Form 8-K
Source: SEC/Edgar
May 09, 2016
Form 8-K
Source: SEC/Edgar
May 08, 2016
Form 8-K
Source: SEC/Edgar
May 08, 2016
Form 8-K
Source: SEC/Edgar
April 21, 2016
Form 8-K
Source: SEC/Edgar
February 15, 2016
Form 8-K
Source: SEC/Edgar
February 09, 2016
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.